Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4,4-DIFLUORO-1,2,3,4-TETRAHYDROISOQUINOLINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

537033-81-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 537033-81-1 Structure
  • Basic information

    1. Product Name: 4,4-DIFLUORO-1,2,3,4-TETRAHYDROISOQUINOLINE
    2. Synonyms: 4,4-DIFLUORO-1,2,3,4-TETRAHYDROISOQUINOLINE;4,4-difluoro-2,3-dihydro-1H-isoquinoline
    3. CAS NO:537033-81-1
    4. Molecular Formula: C9H9F2N
    5. Molecular Weight: 169.17
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 537033-81-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4,4-DIFLUORO-1,2,3,4-TETRAHYDROISOQUINOLINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4,4-DIFLUORO-1,2,3,4-TETRAHYDROISOQUINOLINE(537033-81-1)
    11. EPA Substance Registry System: 4,4-DIFLUORO-1,2,3,4-TETRAHYDROISOQUINOLINE(537033-81-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 537033-81-1(Hazardous Substances Data)

537033-81-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 537033-81-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,7,0,3 and 3 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 537033-81:
(8*5)+(7*3)+(6*7)+(5*0)+(4*3)+(3*3)+(2*8)+(1*1)=141
141 % 10 = 1
So 537033-81-1 is a valid CAS Registry Number.

537033-81-1Downstream Products

537033-81-1Relevant articles and documents

PRMT5 INHIBITORS

-

Page/Page column 66-67, (2021/06/26)

The present invention provides a compound of Formula (I) and the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are PRMT5 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to treat cancer, sickle cell, and hereditary persistence of foetal hemoglobin (HPFH) mutations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 537033-81-1